FORT WORTH, Texas, Jan. 15, 2014 /PRNewswire/ -- Humberto C. Antunes, Galderma worldwide CEO, will receive a "Lifetime in Dermatology Achievement Award" from the Journal of Drugs in Dermatology (JDD) at the upcoming Orlando Dermatology Aesthetic & Clinical Conference (ODAC). The event is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate in Florida.
The ODAC is a distinguished event that delivers a comprehensive report on the practice of dermatology for clinical and aesthetic dermatology practitioners in the 21st century. It delivers the most progressive medical, surgical and cosmetic practices by the foremost leaders in dermatology today.
The Journal of Drugs in Dermatology (JDD), a peer-reviewed publication, was founded by Perry Robins, MD. Now in its 11th year, it offers one of the fastest routes for disseminating dermatologic information.
In 2013, the JDD requested nominations from the entire dermatology community, including the JDD editorial board, authors, and reviewers, for those companies regarded among their peers as the very best thought leaders in a particular dermatology specialty.
Galderma was elected to receive the prestigious JDD Leaders of Distinction Award and chosen as the Leader of Distinction for the "Lifetime in Dermatology Achievement Award."
"Galderma is one of the world's leading pharmaceutical companies in dermatology, and also one of the most generous, much of which would not be possible without Humberto Antunes' leadership, dedication and philanthropy to the industry," said Dr. Robins, ODAC Conference Chair Emeritus and Professor Emeritus of Dermatology at New York University School of Medicine.
"I have had the pleasure of knowing Humberto for many, many years and in
|SOURCE Galderma USA|
Copyright©2012 PR Newswire.
All rights reserved